196 related articles for article (PubMed ID: 29971627)
21. Energy metabolism targeted drugs synergize with photodynamic therapy to potentiate breast cancer cell death.
Feng X; Zhang Y; Wang P; Liu Q; Wang X
Photochem Photobiol Sci; 2014 Dec; 13(12):1793-803. PubMed ID: 25363473
[TBL] [Abstract][Full Text] [Related]
22. 2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors.
Wanyan Y; Xu X; Liu K; Zhang H; Zhen J; Zhang R; Wen J; Liu P; Chen Y
Molecules; 2020 Dec; 25(23):. PubMed ID: 33297583
[TBL] [Abstract][Full Text] [Related]
23. Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells.
Rajh M; Dolinar K; Miš K; Pavlin M; Pirkmajer S
PLoS One; 2016; 11(5):e0154747. PubMed ID: 27135408
[TBL] [Abstract][Full Text] [Related]
24. Enhancing the Therapeutic Efficacy of 2-Deoxyglucose in Breast Cancer Cells Using Cell-cycle Synchronization.
Lee SJ; Park BN; Roh JH; An YS; Hur H; Yoon JK
Anticancer Res; 2016 Nov; 36(11):5975-5980. PubMed ID: 27793923
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic activity of high dose ascorbic acid is enhanced by 2-deoxy-d-glucose in glycolytic melanoma cells.
Hill-Mündel K; Nohr D
Biochem Biophys Res Commun; 2021 Mar; 546():90-96. PubMed ID: 33578294
[TBL] [Abstract][Full Text] [Related]
26. Differential cytotoxicity of the glycolytic inhibitor 2-deoxy-D-glucose in isogenic cell lines varying in their p53 status.
Vibhuti A; Muralidhar K; Dwarakanath BS
J Cancer Res Ther; 2013; 9(4):686-92. PubMed ID: 24518718
[TBL] [Abstract][Full Text] [Related]
27. [Synergistic Effect of 2-deoxy-D-glucose Combined with Hydroxycamptothecin on Apoptosis of Breast Cancer Cells].
Ge XM; Liu YM; Zhang P; Sun XJ; Zhen YN; Li JH; Liu H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 50(4):527-532. PubMed ID: 31642230
[TBL] [Abstract][Full Text] [Related]
28. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death.
Cheng G; Zielonka J; Dranka BP; McAllister D; Mackinnon AC; Joseph J; Kalyanaraman B
Cancer Res; 2012 May; 72(10):2634-44. PubMed ID: 22431711
[TBL] [Abstract][Full Text] [Related]
29. Microarray analysis of breast cancer gene expression profiling in response to 2-deoxyglucose, metformin, and glucose starvation.
Aoun R; El Hadi C; Tahtouh R; El Habre R; Hilal G
Cancer Cell Int; 2022 Mar; 22(1):123. PubMed ID: 35305635
[TBL] [Abstract][Full Text] [Related]
30. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
Wokoun U; Hellriegel M; Emons G; Gründker C
Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075
[TBL] [Abstract][Full Text] [Related]
31. 2-Deoxy-D-glucose Restore Glucocorticoid Sensitivity in Acute Lymphoblastic Leukemia via Modification of N-Linked Glycosylation in an Oxygen Tension-Independent Manner.
Leni Z; Ćwiek P; Dimitrova V; Dulcey AS; Zamboni N; Simillion C; Rossi G; Leibundgut K; Arcaro A
Oxid Med Cell Longev; 2017; 2017():2487297. PubMed ID: 28814986
[TBL] [Abstract][Full Text] [Related]
32. 2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation - Implications for targeting the Warburg effect in cancer cells.
Hong SY; Hagen T
Biochem Biophys Res Commun; 2015 Oct; 465(4):838-44. PubMed ID: 26315267
[TBL] [Abstract][Full Text] [Related]
33. Antiangiogenic activity of 2-deoxy-D-glucose.
Merchan JR; Kovács K; Railsback JW; Kurtoglu M; Jing Y; Piña Y; Gao N; Murray TG; Lehrman MA; Lampidis TJ
PLoS One; 2010 Oct; 5(10):e13699. PubMed ID: 21060881
[TBL] [Abstract][Full Text] [Related]
34. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target.
Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB
Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D
Santos JM; Khan ZS; Munir MT; Tarafdar K; Rahman SM; Hussain F
J Nutr Biochem; 2018 Mar; 53():111-120. PubMed ID: 29216499
[TBL] [Abstract][Full Text] [Related]
36. 2-deoxyglucose induces Noxa-dependent apoptosis in alveolar rhabdomyosarcoma.
Ramírez-Peinado S; Alcázar-Limones F; Lagares-Tena L; El Mjiyad N; Caro-Maldonado A; Tirado OM; Muñoz-Pinedo C
Cancer Res; 2011 Nov; 71(21):6796-806. PubMed ID: 21911456
[TBL] [Abstract][Full Text] [Related]
37. 2-deoxy D-glucose prevents cell surface expression of NKG2D ligands through inhibition of N-linked glycosylation.
Andresen L; Skovbakke SL; Persson G; Hagemann-Jensen M; Hansen KA; Jensen H; Skov S
J Immunol; 2012 Feb; 188(4):1847-55. PubMed ID: 22227571
[TBL] [Abstract][Full Text] [Related]
38. Glycolytic inhibitors 2-deoxyglucose and 3-bromopyruvate synergize with photodynamic therapy respectively to inhibit cell migration.
Feng X; Wang P; Liu Q; Zhang T; Mai B; Wang X
J Bioenerg Biomembr; 2015 Jun; 47(3):189-97. PubMed ID: 25631472
[TBL] [Abstract][Full Text] [Related]
39. Short-term exposure of multicellular tumor spheroids of a human glioma cell line to the glycolytic inhibitor 2-deoxy-D-glucose is more toxic than continuous exposure.
Khaitan D; Chandna S; Dwarakanath SB
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S67-73. PubMed ID: 20009299
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of glycolysis and Src/Akt signaling reduces Caveolin-1-enhanced metastasis.
Simón L; Torres K; Contreras P; Díaz-Valdivia N; Leyton L; Quest AFG
Biomed Pharmacother; 2024 Jul; 176():116841. PubMed ID: 38834004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
